Position in CELC
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$204,563,904
+$31,218,916 QoQ
Shares Held
1,955,304
+28.7% QoQ
Ownership
4.00%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#6
of 274 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 11%
Shared 0%
None 89%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $36,549,056,533 across 410 Biotechnology names. CELC ranks #44 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,871,459 | $5,896,909,829 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,834,688 | $3,014,621,355 | |
| 3 | INCY |
Incyte Corp
|
9,722,336 | $1,102,124,008 | |
| 4 | MRNA |
Moderna, Inc.
|
15,726,193 | $1,101,305,295 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,555,689 | $1,070,369,059 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
4,897,051 | $917,119,711 | |
| 7 | RPRX |
Royalty Pharma plc
|
12,338,229 | $691,804,500 | |
| 8 | INSM |
INSMED Inc
|
6,052,174 | $645,282,791 |
All Filings in CELC
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $204,563,904 | 1,955,304 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $173,344,988 | 1,518,705 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $163,342,901 | 1,637,687 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $35,706,320 | 722,800 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,841,843 | 587,404 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,916,169 | 585,180 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,516,477 | 879,792 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $16,511,557 | 1,107,415 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,192,408 | 439,097 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,269,264 | 336,540 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,322,292 | 296,657 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,517,375 | 275,424 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,875,662 | 261,900 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $321,645 | 31,380 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $439,633 | 31,380 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $315,055 | 31,380 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $285,558 | 31,380 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,391,298 | 148,802 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,903,791 | 144,336 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,489,112 | 138,284 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,101,976 | 129,249 | Shares | Defined | 2021-08-16 | |
| 2020-03-31 | $582,770 | 89,657 | Shares | Defined | 2020-06-19 | |
| No filing history on record for this holder in this stock. | ||||||